Attenuation of ethanol withdrawal syndrome by extract of Hypericum perforatum in Wistar rats

被引:15
作者
Coskun, Ilke
Uzbay, I. Tayfun [1 ]
Ozturk, Nilgun
Ozturk, Yusuf
机构
[1] Gulhane Mil Med Acad, Fac Med, Dept Med Pharmacol, Psychopharmacol Res Unit, TR-06018 Ankara, Turkey
[2] Anadoli Univ, Fac Pharm, Dept Pharmacol, TR-26470 Eskisehir, Turkey
[3] Anadoli Univ, Fac Pharm, Dept Pharmacognosy, TR-26470 Eskisehir, Turkey
关键词
ethanol; ethanol withdrawal; Hypericum perforatum; rat(s); St John's wort;
D O I
10.1111/j.1472-8206.2006.00432.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of Hypericum perforatum (St John's wort) on ethanol withdrawal syndrome have been investigated in ethanol-dependent rats. Adult male Wistar rats were subjects. Ethanol (7.2% v/v) was given to rats by a liquid diet for 15 days. Hypericum perforatum extract (HPE) (25-200 mg/kg) and saline were injected to rats intraperitoneally just before ethanol withdrawal. After second, fourth and sixth hour of ethanol withdrawal, rats were observed for 5 min, and withdrawal signs that included locomotor hyperactivity, stereotyped behavior and tremors were recorded or rated. A second series of injections was given at 6 h after the first one, and subjects were then tested for audiogenic seizures. HPE (25-200 mg/kg) produced some dose-dependent and significant inhibitory effects on locomotor hyperactivity at second and sixth hour of ethanol withdrawal. In addition, it significantly reduced the number of stereotyped behaviors at the same dose range. HPE (50 and 100 mg/kg) produced some significant inhibitory effects on tremor and audiogenic seizures during withdrawal period. These results suggest that HPE has some beneficial effects on ethanol withdrawal syndrome in rats.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 51 条
[1]   NITRIC OXIDE-RELATED AGENTS ALTER ALCOHOL-WITHDRAWAL IN MALE-RATS [J].
ADAMS, ML ;
SEWING, BN ;
CHEN, JL ;
MEYER, ER ;
CICERO, TJ .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1995, 19 (01) :195-199
[2]   Neuropharmacology of St. John's wort (Hypericum) [J].
Bennett, DA ;
Phun, L ;
Polk, JF ;
Voglino, SA ;
Zlotnik, V ;
Raffa, RB .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (11) :1201-1208
[3]   Effects of the total extract and fractions of hypericum perforatum in animal assays for antidepressant activity [J].
Butterweck, V ;
Wall, A ;
LieflanderWulf, U ;
Winterhoff, H ;
Nahrstedt, A .
PHARMACOPSYCHIATRY, 1997, 30 :117-124
[4]   Hormesis: U-shaped dose responses and their centrality in toxicology [J].
Calabrese, EJ ;
Baldwin, LA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (06) :285-291
[5]   Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat [J].
Calapai, G ;
Crupi, A ;
Firenzuoli, F ;
Costantino, G ;
Inferrera, G ;
Campo, GM ;
Caputi, AP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (06) :723-728
[6]   In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract [J].
Cott, JM .
PHARMACOPSYCHIATRY, 1997, 30 :108-112
[7]   Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism [J].
De Vry, J ;
Maurel, S ;
Schreiber, R ;
de Beun, R ;
Jentzsch, KR .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (06) :461-468
[8]   Alcohol and withdrawal: from animal research to clinical issues [J].
De Witte, P ;
Pinto, E ;
Ansseau, M ;
Verbanck, P .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (03) :189-197
[9]   St. John's wort (Hypericum perforatum):: a review of the current pharmacological, toxicological, and clinical literature [J].
Greeson, JM ;
Sanford, B ;
Monti, DA .
PSYCHOPHARMACOLOGY, 2001, 153 (04) :402-414
[10]   Anticonvulsant effect of Hypericum perforatum:: role of nitric oxide [J].
Hosseinzadeh, H ;
Karimi, GR ;
Rakhshanizadeh, M .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 98 (1-2) :207-208